CLARIX FLO Inhibits DRG Adhesion-Induced Neuropathic Pain Through the CD44–TRPV1 Signaling Pathway
International Journal of Molecular Sciences · 28.03.2026 · 27 (7) · 3096
DOI: 10.3390/ijms27073096 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2026. Verfasst von Chia-Chi Kung und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Fu Jen Catholic University, No. 510 Zhongzheng Rd., Xinzhuang Dist., New Taipei 24205, Taiwan. Hauptthemen laut MEDLINE: Neuralgia, Signal Transduction, Hyaluronan Receptors, Ganglia, Spinal. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fu Jen Catholic University Hospital, Irene and Paul Chair Professor ship, College of Medicine, Fu Jen Catholic University, the National Science and Technology Council of the Republic of China (Taiwan).
Abstract (Originalsprache)
DRG adhesion is a key pathological feature of failed back surgery syndrome and a major cause of neuropathic pain. DRG, or epidural adhesion, commonly results from spinal surgery, leakage of disk material into the epidural space, or inflammation. To better mimic this clinical condition, we developed a novel and reliable animal model of DRG adhesion-induced neuropathic pain. Using this model, we investigated the therapeutic potential and underlying mechanisms of CLARIX FLO, a sterile, particulate human amniotic membrane and umbilical cord tissue product. Our results demonstrate that CLARIX FLO exerts significant analgesic and anti-inflammatory effects in the DRG adhesion model. The application of CLARIX FLO to the injured DRG markedly attenuated mechanical allodynia. CLARIX FLO treatment also reduced outer sheath thickening, suppressed the inflammatory microenvironment, and decreased hypersensitivity of isolectin B4-positive neurons. Mechanistically, CD44 was identified as a potential downstream mediator of CLARIX FLO. Furthermore, a high dose of HC-HA/PTX3, the key bioactive component of CLARIX FLO, effectively reversed mechanical allodynia and inflammation. Notably, CLARIX FLO inhibited the overexpression of TNF-α and TRPV1 adhering to the DRG. In this study, we demonstrated that CLARIX FLO effectively alleviates DRG adhesion-induced neuropathic pain through a CD44–TRPV1-dependent mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, Fu Jen Catholic University, No. 510 Zhongzheng Rd., Xinzhuang Dist., New Taipei 24205, Taiwan.
- Department of Anesthesiology, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei 24352, Taiwan.
- Department of Surgery, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei 24352, Taiwan.
ORCID-Profile: Chao-Chiang Tu, Chao-Hsien Sung, Chun-Hsien Fu, Chih-Li Chen
Förderung
- Fu Jen Catholic University Hospital
- Irene and Paul Chair Professor ship, College of Medicine, Fu Jen Catholic University
- the National Science and Technology Council of the Republic of China (Taiwan)
- Irene and Paul Chair Professorship, College of Medicine, Fu Jen Catholic University
- Ministry of Science and Technology
Zitieren
APA
Kung, C. C., Dai, S. P., Tu, C. C., Tsai, T. A., Chen, P. H., Sung, C. H., Fu, C. H., Liu, J. H., & Chen, C. L. (2026). CLARIX FLO Inhibits DRG Adhesion-Induced Neuropathic Pain Through the CD44–TRPV1 Signaling Pathway. International Journal of Molecular Sciences, 27(7), 3096. https://doi.org/10.3390/ijms27073096
Vancouver
Kung CC, Dai SP, Tu CC, Tsai TA, Chen PH, Sung CH, et al. CLARIX FLO Inhibits DRG Adhesion-Induced Neuropathic Pain Through the CD44–TRPV1 Signaling Pathway. International Journal of Molecular Sciences. 2026;27(7):3096. doi:10.3390/ijms27073096
BibTeX
@article{Kung2026,
author = {Kung, Chia-Chi and Dai, Shih-Ping and Tu, Chao-Chiang and Tsai, Tsung-An and Chen, Po-Heng and Sung, Chao-Hsien and Fu, Chun-Hsien and Liu, Jen-Hao and Chen, Chih-Li},
title = {CLARIX FLO Inhibits DRG Adhesion-Induced Neuropathic Pain Through the CD44–TRPV1 Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3096},
doi = {10.3390/ijms27073096}
}
EUVIMED